As an IE20 winner, RxPrism will be able to participate in key events at London Tech Week in June 2017
London & Partners, the official promotional agency of the Mayor of London, has declared RxPrism Health Systems among the 20 most innovative and high growth companies with global aspirations in India.
The India Emerging 20 (IE20) award’a panel judges for the final round were Kiran Mazumdar-Shaw, the CMD, Biocon ; David Slater, the Director of International Trade and Investment, London & Partners; Mark Ling, the Head of International Large Corporates, Santander UK Corporate & Commercial; and Natarajan R , the COO and CFO, RNT Capital Advisers, a venture fund launched by Tata Sons.
As an IE20 winner, RxPrism will have the unique opportunity to participate in key events at the London Tech Week in June 2017, interact with the who’s who of the industry, foster global alliances and partnerships, and expand its footprints further.
Dr Maruthi Viswanathan, Founder and CEO, RxPrism, said, “This recognition validates our drive for high performance, innovation, differentiation, and global scalability. Awards like IE20 motivate us to surpass all expectations and unceasingly deliver the best in healthcare digital innovation.”
- Advertisement -
Comments are closed.